Maria E. Navas

Maria E. Navas

Auto-generated profile, based on publicly available information

Maria E. Navas

VA Northeast Ohio Health Care System , Cleveland, OH

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2016 in JMM Case Reports
Verified
Journal Article
Open access
MNMaria E. Navas
Maria E. Navas
RJRobin Jump
Robin Jump
DCDavid H. Canaday
David H. Canaday
MWMaria D. Wnek
Maria D. Wnek
DSDhruba J. SenGupta
Dhruba J. SenGupta
MBMelissa Bell
Melissa Bell
Introduction: Anaerobic acid fast bacilli (AFB) have not been previously reported in clinical microbiology. This is the second case report of a novel anaerobic AFB causing disease in humans. Case presentation: An anaerobic AFB was isolated from an abdominal wall abscess in a 64–year-old Caucasian diabetic male, who underwent distal pancreatectomy and splenectomy for resection of a pancreatic neuroendocrine tumour. The isolated bacteria were gram-variable and acid-fast, consisting of small irregular rods. The 16S rRNA gene sequence analysis showed that the isolate is a novel organism described in the literature only once before. The organism was studied at the CDC (Centers for Disease Control and Prevention) by the same group that worked with the isolates from the previous report; their findings suggest that the strain belongs to the suborder Corynebacterineae. Conclusion: This is the fifth reported case of an anaerobic AFB involved in clinical disease; its microbiological features and 16S RNA sequence are identical to previously reported cases. Clinical disease with this organism seems to be associated with recent history of surgery and abscess formation in deep soft tissues. Acquisition from surgical material is uncertain but seems unlikely.

22 February 2022 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
LJLucas Jones
Lucas Jones
ECErnest R. Chan
Ernest R. Chan
JCJennifer L. Cadnum
Jennifer L. Cadnum
SRSarah N. Redmond
Sarah N. Redmond
MNMaria E. Navas
Maria E. Navas
CDCurtis J. Donskey
Curtis J. Donskey
Objective: To investigate a cluster of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in employees working on 1 floor of a hospital administration building.Methods: Contact tracing was performed to identify potential exposures and all employees were tested for SARS-CoV-2. Whole-genome sequencing was performed to determine the relatedness of SARS-CoV-2 samples from infected personnel and from control cases in the healthcare system with coronavirus disease 2019 (COVID-19) during the same period. Carbon dioxide levels were measured during a workday to assess adequacy of ventilation; readings >800 parts per million (ppm) were considered an indication of suboptimal ventilation. To assess the potential for airborne transmission, DNA-barcoded aerosols were released, and real-time polymerase chain reaction was used to quantify particles recovered from air samples in multiple locations.Results: Between December 22, 2020, and January 8, 2021, 17 coworkers tested positive for SARS-CoV-2, including 13 symptomatic and 4 asymptomatic individuals. Of the 5 cluster SARS-CoV-2 samples sequenced, 3 were genetically related, but these employees denied higher-risk contacts with one another. None of the sequences from the cluster were genetically related to the 17 control sequences of SARS-CoV-2. Carbon dioxide levels increased during a workday but never exceeded 800 ppm. DNA-barcoded aerosol particles were dispersed from the sites of release to locations throughout the floor; 20% of air samples had >1 log10 particles.Conclusions: In a hospital administration building outbreak, sequencing of SARS-CoV-2 confirmed transmission among coworkers. Transmission occurred despite the absence of higher-risk exposures and in a setting with adequate ventilation based on monitoring of carbon dioxide levels.

17 April 2023 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
MTMaria M. Torres-Teran
Maria M. Torres-Teran
MNMaria E. Navas
Maria E. Navas
NKNataliya M. Kachaluba
Nataliya M. Kachaluba
JMJosh M. Meyer
Josh M. Meyer
CDCurtis J. Donskey
Curtis J. Donskey
To the Editor-During the coronavirus disease 2019 (COVID-19) pandemic, screening of asymptomatic patients for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the time of healthcare facility admission has often been used in an effort to reduce the risk of nosocomial transmission. 1-3 However, the Society for Healthcare Epidemiology of America recently recommended against routine use of asymptomatic screening in healthcare facilities, including admission screening. 4 Such testing is of unclear benefit when other control measures are in place and may result in unintended adverse consequences, including delays in medical care and unnecessary isolation and treatment of noninfectious patients. 4 In Veterans' Affairs (VA) hospitals, it is recommended that all new admissions be screened for SARS-CoV-2 using a polymerase chain reaction (PCR) test. At this stage of the pandemic, PCR screening can be problematic because tests often remain positive for months after COVID-19, and undiagnosed infections are not uncommon. 1,4,5 The cycle threshold (Ct) of the PCR test can be useful in assessing whether asymptomatic patients are infectious because high Ct values, which correlate with low viral burden, suggest a remote infection. 1 In previous studies, many asymptomatic patients with positive PCR tests have been deemed noninfectious based on clinical presentation, serology, and high Ct value. 1,5 Here, we conducted a retrospective study to evaluate the potential benefits and adverse consequences associated with screening asymptomatic patients being admitted to a VA hospital. The Cleveland VA Medical Center's Research and Development Committee determined that the study was a nonresearch, qualityimprovement project not requiring approval from the institutional review board. Between September 1, 2022, and January 31, 2023, we obtained the Ct values of all patients testing positive for SARS-CoV-2 on admission except those with prior COVID-19 within 90 days. The Xpert Xpress CoV-2 plus assay (Cepheid) was used for testing. Ct values were not provided in the medical record but were available to infectious diseases providers upon request. Medical records and infection control databases were reviewed to obtain information on symptoms, prior COVID-19 diagnosis, test

12 October 2024 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
MNMaria E Navas
Maria E Navas
LMLewis Musoke
Lewis Musoke
PEPuja Van Epps
Puja Van Epps
KAKristen Allen
Kristen Allen
KCKc Coffey
Kc Coffey
JKJ Stacey Klutts
J Stacey Klutts
Rectal and pharyngeal infections with gonorrhea and chlamydia are of concern because they are associated with higher risk of HIV acquisition. Extragenital screening in asymptomatic persons at high risk may have the potential to reduce the incidence of these sexually transmitted infections (STIs). Several testing platforms are available for the testing of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) using nucleic acid amplification tests (NAATs). Self-collected extragenital samples are currently not approved by the US Food and Drug Administration in any NAAT platform. This study compares the analytical performance of self-collected extragenital specimens to that of clinician-collected specimens. We performed a multicenter/multiplatform validation study as a National Veterans Health Administration Pathology and Laboratory Medicine quality improvement project, with 9 different participating sites. Self-collected specimens were obtained at the same time as clinician-collected specimens. Clinician-collected specimens were used as the gold standard to evaluate the sensitivity and specificity of self-collection. A total of 2324 individual tests were analyzed (501 rectal and 661 oropharyngeal). The sensitivity was 94.44% for CT and 100% for NG for rectal specimens, whereas it was 100% for CT and 97.22% for NG for oral specimens. Specificity for oral specimens was 99.85% for CT and 99.36% for NG, whereas for rectal specimens, it was 99% for CT and NG. Self-collected specimens for extragenital CT/NG testing are highly sensitive and specific, with negative predictive values of 100%. Self-collection has the potential to overcome a major barrier for STI screening by providing an accessible, convenient, and patient-centered alternative.

21 October 2022 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
SRSarah N. Redmond
Sarah N. Redmond
DLDaniel F. Li
Daniel F. Li
HGHussein Abou Ghaddara
Hussein Abou Ghaddara
MHMuhammed F. Haq
Muhammed F. Haq
LJLucas D. Jones
Lucas D. Jones
CDCurtis J. Donskey
Curtis J. Donskey

2 January 2025 in American Journal of Clinical Pathology
Verified
Journal Article
Closed access
MNMaria E Navas
Maria E Navas
JKJ Stacey Klutts
J Stacey Klutts